世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

免疫組織化学市場 - 世界の産業規模、シェア、動向、機会、予測、2018-2028F製品別(抗体、装置、試薬、キット)、用途別(診断、薬物検査、法医学用途)、エンドユーザー別(病院・診断研究所、研究機関、その他)、地域別、競合他社別


Immunohistochemistry Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028FSegmented by Product (Antibodies, Equipment, Reagents, Kits), By Application (Diagnostics, Drug Testing, Forensic applications), By End User (Hospitals & Diagnostic Laboratories, Research Institutes, Others), By Region and By Competition

世界の免疫組織化学市場は、予測期間中に目覚ましい成長を遂げると予測されている。これは、世界中で技術的に高度な免疫組織化学ソリューションが導入されるとともに、免疫組織化学における自動化と機械学習の導... もっと見る

 

 

出版社 出版年月 電子版価格 ページ数 言語
TechSci Research
テックサイリサーチ
2023年7月1日 US$4,900
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら
113 英語

 

サマリー

世界の免疫組織化学市場は、予測期間中に目覚ましい成長を遂げると予測されている。これは、世界中で技術的に高度な免疫組織化学ソリューションが導入されるとともに、免疫組織化学における自動化と機械学習の導入に対する需要が高まっていることに起因している。さらに、製品承認の増加や、疾患診断のための技術的に高度なIHCシステムの発売が、予測期間中の市場の成長をさらに促進している。同様に、製薬業界やバイオテクノロジー業界における研究開発費の増加は、市場の成長を促進する主な要因である。さらに、個別化医療への嗜好の高まり、がんゲノム研究、患者参加要件の増加が、予測期間中の市場の需要を促進すると予想される。同様に、病理学、神経病理学、血液病理学における抗体の使用量の増加は、予測期間中に免疫組織化学市場の需要をさらに高めると予想される。2021年8月、FDAは抗PD-1免疫療法の対象となるdMMR固形腫瘍患者を同定するためのRocheのVENTANA MMR RxDx Panelを承認した。
慢性疾患の有病率の増加

老年人口の増加とともに、癌の有病率が高まっていることは、予測期間中に市場の成長をさらに押し上げると予想される主要因の1つである。2020年7月に発表された合同調査委員会の報告書欧州委員会によると、2020年には欧州連合で約270万人(非黒色腫がんを除く)のがん患者が新たに診断されると推定され、乳がんが最も多く、2020年には約35万5,000人が新たにがんと診断される。さらに、慢性腎臓障害の有病率の増加は、予測期間中に有利な成長をもたらすと予想される。さらに、酵素、腫瘍特異的抗原、腫瘍抑制遺伝子、癌遺伝子、腫瘍細胞増殖マーカーを同定することによる腫瘍の分析需要の高まりは、予測期間中に免疫組織化学市場の需要を高めると予想される。さらに、心血管疾患、心臓病、喘息、慢性閉塞性肺疾患の罹患率の増加と病院を訪れる患者数の増加は、予測期間中に免疫組織化学市場の需要を高めることができる。

個別化医療への需要の高まり

非小細胞肺がん患者に対する個別化医療への需要の高まりは、予測期間中の免疫組織化学の需要を高めた。さらに、この技術は、可能な限り完全で正確な腫瘍の組織学的サブタイピングを行うことにより、適切な治療決定を行うのに役立つ。同様に、BRAF V600EやIDH1 R132Hのような変異タンパク質を検出できる免疫組織化学アッセイの利用可能性が高まっていることも、予測期間中の市場をさらに牽引するであろう。免疫組織化学検査は、分子生物学的検査の代替または補助として有用である。これらの技術は再現性が高く、技術的な複雑さや解釈の複雑さを伴わず、より安価に入手できる。多重免疫組織化学アッセイや変異特異的免疫組織化学アッセイの開発が進んでいることは、重要な技術革新であり、予測期間中の市場成長をさらに促進すると期待されている。2020年7月にLaboratory Investigation誌に発表された研究によると、Covid-19感染の検出には免疫組織化学(IHC)アッセイとin situハイブリダイゼーション(ISH)アッセイが利用された。

市場セグメンテーション

世界の免疫組織化学市場は、製品、用途、エンドユーザー、地域によって区分することができる。製品ベースでは、市場は抗体、機器、試薬、キットに区分される。用途別では、市場は診断、薬物検査、法医学用途に区分される。エンドユーザー別では、市場はさらに病院・診断ラボ、研究機関、その他に分けられる。地域別では、アジア太平洋、欧州、中東・アフリカ、南米の中で北米が市場を支配している。様々な国の中で、米国が世界の免疫組織化学市場を独占した。

最近の開発
- 2022年6月、Roche社はHPVセルフサンプリングソリューションを発売し、子宮頸がん検診の選択肢を拡大した。
- 2022年2月、Modernaとサーモフィッシャーサイエンティフィックは、COVID-19およびこのパイプラインにある他の治験用mRNA医薬品の診断用Spikevaxワクチンの米国での製造に関する長期戦略的提携を発表した。
- 2022年2月、キャピラリー電気泳動と呼ばれる新しい遺伝子分析装置がサンガーシーケンスとフラグメント分析に高度な機能をもたらし、臨床研究の改善と科学的発見の進展に不可欠なサンガーシーケンスとフラグメント分析を可能にした。
市場参入企業
Thermo Fisher Scientific Inc.、F.Hoffmann-La Roche Ltd.、Merck KGaA.、Danaher Corporation.、Perkinelmer, Inc.、Bio-Rad Laboratories, Inc.、Cell Signaling Technology Inc.、Bio SB.、Agilent Technologies, Inc.は、世界の免疫組織化学市場で事業を展開する大手企業である。

レポートの範囲
本レポートでは、世界の免疫組織化学市場を、業界動向に加えて、以下のカテゴリーに分類しています:
- 免疫組織化学市場、製品別
o 抗体
機器
試薬
キット
- 免疫組織化学市場:用途別
診断
o 薬物検査
o 法医学アプリケーション
- 免疫組織化学市場:エンドユーザー別
o 病院・診断研究所
o 研究機関
o その他
- 免疫組織化学市場:地域別
o 北米
 米国
 カナダ
 メキシコ
o ヨーロッパ
 フランス
 ドイツ
 イギリス
 イタリア
 スペイン
o アジア太平洋
 中国
 インド
 日本
 韓国
 オーストラリア
南米
 ブラジル
 アルゼンチン
 コロンビア
中東・アフリカ
 南アフリカ
 サウジアラビア
 UAE
競争環境
企業プロフィール:免疫組織化学の世界市場における主要企業の詳細分析。
利用可能なカスタマイズ:
TechSci Research社は、与えられた市場データをもとに、企業固有のニーズに応じたカスタマイズを提供します。このレポートでは以下のカスタマイズが可能です:
企業情報
- 追加市場参入企業(最大5社)の詳細分析とプロファイリング

ページTOPに戻る


目次

1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Immunohistochemistry Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Product (Antibodies, Equipment, Reagents, Kits)
5.2.2. By Application (Diagnostics, Drug Testing, Forensic applications)
5.2.3. By End User (Hospitals & Diagnostic Laboratories, Research Institutes, Others)
5.2.4. By Region (North America, Europe, Asia Pacific, South America, Middle East & Africa)
5.2.5. By Company (2022)
5.3. Market Map
5.3.1 By Product
5.3.2 By Application
5.3.3 By End User
5.3.4 By Region
6. North America Immunohistochemistry Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Product (Antibodies, Equipment, Reagents, Kits)
6.2.2. By Application (Diagnostics, Drug Testing, Forensic applications)
6.2.3. By End User (Hospitals & Diagnostic Laboratories, Research Institutes, Others)
6.2.4. By Country
6.3. North America: Country Analysis
6.3.1. United States Immunohistochemistry Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Product
6.3.1.2.2. By Application
6.3.1.2.3. By End User
6.3.2. Canada Immunohistochemistry Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Product
6.3.2.2.2. By Application
6.3.2.2.3. By End User
6.3.3. Mexico Immunohistochemistry Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Product
6.3.3.2.2. By Application
6.3.3.2.3. By End User
7. Europe Immunohistochemistry Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Product (Antibodies, Equipment, Reagents, Kits)
7.2.2. By Application (Diagnostics, Drug Testing, Forensic applications)
7.2.3. By End User (Hospitals & Diagnostic Laboratories, Research Institutes, Others)
7.2.4. By Country
7.3. Europe: Country Analysis
7.3.1. France Immunohistochemistry Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Product
7.3.1.2.2. By Application
7.3.1.2.3. By End User
7.3.2. Germany Immunohistochemistry Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Product
7.3.2.2.2. By Application
7.3.2.2.3. By End User
7.3.3. United Kingdom Immunohistochemistry Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Product
7.3.3.2.2. By Application
7.3.3.2.3. By End User
7.3.4. Italy Immunohistochemistry Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Product
7.3.4.2.2. By Application
7.3.4.2.3. By End User
7.3.5. Spain Immunohistochemistry Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Product
7.3.5.2.2. By Application
7.3.5.2.3. By End User
8. Asia-Pacific Immunohistochemistry Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Product (Antibodies, Equipment, Reagents, Kits)
8.2.2. By Application (Diagnostics, Drug Testing, Forensic applications)
8.2.3. By End User (Hospitals & Diagnostic Laboratories, Research Institutes, Others)
8.2.4. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Immunohistochemistry Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Product
8.3.1.2.2. By Application
8.3.1.2.3. By End User
8.3.2. India Immunohistochemistry Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Product
8.3.2.2.2. By Application
8.3.2.2.3. By End User
8.3.3. Japan Immunohistochemistry Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Product
8.3.3.2.2. By Application
8.3.3.2.3. By End User
8.3.4. South Korea Immunohistochemistry Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Product
8.3.4.2.2. By Application
8.3.4.2.3. By End User
8.3.5. Australia Immunohistochemistry Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Product
8.3.5.2.2. By Application
8.3.5.2.3. By End User
9. South America Immunohistochemistry Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Product (Antibodies, Equipment, Reagents, Kits)
9.2.2. By Application (Diagnostics, Drug Testing, Forensic applications)
9.2.3. By End User (Hospitals & Diagnostic Laboratories, Research Institutes, Others)
9.2.4. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Immunohistochemistry Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Product
9.3.1.2.2. By Application
9.3.1.2.3. By End User
9.3.2. Argentina Immunohistochemistry Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Product
9.3.2.2.2. By Application
9.3.2.2.3. By End User
9.3.3. Colombia Immunohistochemistry Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Product
9.3.3.2.2. By Application
9.3.3.2.3. By End User
10. Middle East and Africa Immunohistochemistry Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Product (Antibodies, Equipment, Reagents, Kits)
10.2.2. By Application (Diagnostics, Drug Testing, Forensic applications)
10.2.3. By End User (Hospitals & Diagnostic Laboratories, Research Institutes, Others)
10.2.4. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa Immunohistochemistry Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Product
10.3.1.2.2. By Application
10.3.1.2.3. By End User
10.3.2. Saudi Arabia Immunohistochemistry Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Product
10.3.2.2.2. By Application
10.3.2.2.3. By End User
10.3.3. UAE Immunohistochemistry Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Product
10.3.3.2.2. By Application
10.3.3.2.3. By End User
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
12.1. Recent Development
12.2. Mergers & Acquisitions
12.3. Product Launches
13. Global Immunohistochemistry Market: SWOT Analysis
14. Porter’s Five Forces Analysis
14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products
15. Competitive Landscape
15.1. Business Overview
15.2. Product Offerings
15.3. Recent Developments
15.4. Financials (As Reported)
15.5. Key Personnel
15.6. SWOT Analysis
15.6.1 Thermo Fisher Scientific Inc.
15.6.2 F.Hoffmann-La Roche Ltd.
15.6.3 Merck KGaA.
15.6.4 Danaher Corporation.
15.6.5 Perkinelmer, Inc.
15.6.6 Bio-Rad Laboratories, Inc.
15.6.7 Cell Signaling Technology Inc.
15.6.8 Bio SB.
15.6.9 Agilent Technologies, Inc.
15.6.10 Abcam Plc.
16. Strategic Recommendations

 

ページTOPに戻る


 

Summary

Global Immunohistochemistry market is anticipated to witness impressive growth during the forecast period. This can be ascribed to the rising demand for the implementation of automation and machine learning in immunohistochemistry, along with the introduction of technologically advanced immunohistochemistry solutions across the globe. Moreover, the rise in product approvals and the launch of technologically advanced IHC systems for disease diagnosis are further driving the growth of the market during the forecast period. Similarly, growing research and development expenditures in the pharmaceutical and biotechnology industries are the major factors driving the growth of the market. Moreover, growing preference for personalized medicine, cancer genomics studies, and increasing patient engagement requirements is expected to drive the demand for the market during the forecast period. Similarly, the growing usage of antibodies in pathology, neuropathology, and hematopathology is expected to further enhance the demand for the immunohistochemistry market during the forecast period. In August 2021, the FDA approved Roche’s VENTANA MMR RxDx Panel to identify dMMR solid tumor patients eligible for anti-PD-1 immunotherapy.
Growing Prevalence of Chronic Diseases

The growing prevalence of cancer, along with the increasing geriatric population, is one of the major factors which is expected to further boost the growth of the market during the forecast period. As per the Joint Research Commission’s report European Commission released in July 2020, it was estimated that in 2020 about 2.7 million (excluding non-melanoma cancer) new cancer cases would be diagnosed in the European Union, and breast cancer will be the most prevalent form of cancer with about 355,000 new cases in 2020. Moreover, the growing prevalence of chronic kidney disorders is expected to create lucrative growth during the forecast period. Furthermore, growing demand for analyzing tumors by identification of enzymes, tumor-specific antigens, tumor suppressor genes, oncogenes, and tumor cell proliferation markers is expected to enhance demand for the immunohistochemistry market during the forecast period. Moreover, the growing incidence of cardiovascular diseases, heart diseases, asthma, and chronic obstructive pulmonary diseases, along with the rising number of patient visits to hospitals, can enhance the demand for the immunohistochemistry market during the forecast period.

Growing Demand for Personalized Medicine

The growing demand for personalized medicine for non-small cell lung cancer patients enhanced the demand for immunohistochemistry during the forecast period. Moreover, this technique helps in making appropriate treatment decisions by performing the most complete and accurate histological subtyping of tumors possible, which can enhance the demand for the market over the years. Similarly, the growing availability of immunohistochemistry assays that can detect mutant proteins such as BRAF V600E and IDH1 R132H will further drive the market during the forecast period. It can provide a helpful replacement or adjunct for molecular testing. These techniques are highly reproducible, entail reasonable technical and interpretation complexity, and are also available at lesser costs. The growing development of multiplex and mutation-specific immunohistochemistry assays represents important innovations that are expected to further drive the growth of the market during the forecast period. According to research published in the Laboratory Investigation journal in July 2020, the immunohistochemical (IHC) and in situ hybridization (ISH) assays were utilized for detecting Covid-19 infection.

Market Segmentation

Global Immunohistochemistry market can be segmented on the basis of product, application, end-user, and by region. Based on the product, the market can be segmented into antibodies, equipment, reagents, and kits. On the basis of application, the market can be segmented into diagnostics, drug testing, and forensic applications. Based on end-user, the market can be further divided into hospitals & diagnostic laboratories, research institutes, and others. On the basis of region, North America dominated the market among Asia Pacific, Europe, Middle East & Africa, and South America. Among the different countries, the United States dominated the global immunohistochemistry market on account of the growing prevalence of chronic diseases in the country.

Recent Development
• In June 2022, Roche launched HPV self-sampling solution and expanded cervical cancer screening options.
• In February 2022, Moderna and Thermo Fisher Scientific announced a long-term strategic collaboration for manufacturing of Spikevax vaccine in the U.S. for diagnosis of COVID-19 and other investigational mRNA medicines in this pipeline.
• In February 2022, a new genetic analyzer brought advanced capabilities to sanger sequencing and fragment analysis, which is called capillary electrophoresis, and it enables sanger sequencing and fragment analysis, which is essential for improving clinical research and advancing scientific discovery.
Market Players
Thermo Fisher Scientific Inc., F.Hoffmann-La Roche Ltd., Merck KGaA., Danaher Corporation., Perkinelmer, Inc., Bio-Rad Laboratories, Inc., Cell Signaling Technology Inc., Bio SB., Agilent Technologies, Inc. are some of the leading players operating in the global Immunohistochemistry market.

Report Scope:
In this report, global Immunohistochemistry market has been segmented into the following categories, in addition to the industry trends, which have also been detailed below:
• Immunohistochemistry Market, By Product:
o Antibodies
o Equipment
o Reagents
o Kits
• Immunohistochemistry Market, By Application:
o Diagnostics
o Drug Testing
o Forensic applications
• Immunohistochemistry Market, By End User:
o Hospitals & Diagnostic Laboratories
o Research Institutes
o Others
• Immunohistochemistry Market, By Region:
o North America
 United States
 Canada
 Mexico
o Europe
 France
 Germany
 United Kingdom
 Italy
 Spain
o Asia Pacific
 China
 India
 Japan
 South Korea
 Australia
o South America
 Brazil
 Argentina
 Colombia
o Middle East & Africa
 South Africa
 Saudi Arabia
 UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Global Immunohistochemistry Market.
Available Customizations:
With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:
Company Information
• Detailed analysis and profiling of additional market players (up to five).



ページTOPに戻る


Table of Contents

1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Immunohistochemistry Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Product (Antibodies, Equipment, Reagents, Kits)
5.2.2. By Application (Diagnostics, Drug Testing, Forensic applications)
5.2.3. By End User (Hospitals & Diagnostic Laboratories, Research Institutes, Others)
5.2.4. By Region (North America, Europe, Asia Pacific, South America, Middle East & Africa)
5.2.5. By Company (2022)
5.3. Market Map
5.3.1 By Product
5.3.2 By Application
5.3.3 By End User
5.3.4 By Region
6. North America Immunohistochemistry Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Product (Antibodies, Equipment, Reagents, Kits)
6.2.2. By Application (Diagnostics, Drug Testing, Forensic applications)
6.2.3. By End User (Hospitals & Diagnostic Laboratories, Research Institutes, Others)
6.2.4. By Country
6.3. North America: Country Analysis
6.3.1. United States Immunohistochemistry Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Product
6.3.1.2.2. By Application
6.3.1.2.3. By End User
6.3.2. Canada Immunohistochemistry Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Product
6.3.2.2.2. By Application
6.3.2.2.3. By End User
6.3.3. Mexico Immunohistochemistry Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Product
6.3.3.2.2. By Application
6.3.3.2.3. By End User
7. Europe Immunohistochemistry Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Product (Antibodies, Equipment, Reagents, Kits)
7.2.2. By Application (Diagnostics, Drug Testing, Forensic applications)
7.2.3. By End User (Hospitals & Diagnostic Laboratories, Research Institutes, Others)
7.2.4. By Country
7.3. Europe: Country Analysis
7.3.1. France Immunohistochemistry Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Product
7.3.1.2.2. By Application
7.3.1.2.3. By End User
7.3.2. Germany Immunohistochemistry Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Product
7.3.2.2.2. By Application
7.3.2.2.3. By End User
7.3.3. United Kingdom Immunohistochemistry Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Product
7.3.3.2.2. By Application
7.3.3.2.3. By End User
7.3.4. Italy Immunohistochemistry Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Product
7.3.4.2.2. By Application
7.3.4.2.3. By End User
7.3.5. Spain Immunohistochemistry Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Product
7.3.5.2.2. By Application
7.3.5.2.3. By End User
8. Asia-Pacific Immunohistochemistry Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Product (Antibodies, Equipment, Reagents, Kits)
8.2.2. By Application (Diagnostics, Drug Testing, Forensic applications)
8.2.3. By End User (Hospitals & Diagnostic Laboratories, Research Institutes, Others)
8.2.4. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Immunohistochemistry Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Product
8.3.1.2.2. By Application
8.3.1.2.3. By End User
8.3.2. India Immunohistochemistry Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Product
8.3.2.2.2. By Application
8.3.2.2.3. By End User
8.3.3. Japan Immunohistochemistry Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Product
8.3.3.2.2. By Application
8.3.3.2.3. By End User
8.3.4. South Korea Immunohistochemistry Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Product
8.3.4.2.2. By Application
8.3.4.2.3. By End User
8.3.5. Australia Immunohistochemistry Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Product
8.3.5.2.2. By Application
8.3.5.2.3. By End User
9. South America Immunohistochemistry Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Product (Antibodies, Equipment, Reagents, Kits)
9.2.2. By Application (Diagnostics, Drug Testing, Forensic applications)
9.2.3. By End User (Hospitals & Diagnostic Laboratories, Research Institutes, Others)
9.2.4. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Immunohistochemistry Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Product
9.3.1.2.2. By Application
9.3.1.2.3. By End User
9.3.2. Argentina Immunohistochemistry Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Product
9.3.2.2.2. By Application
9.3.2.2.3. By End User
9.3.3. Colombia Immunohistochemistry Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Product
9.3.3.2.2. By Application
9.3.3.2.3. By End User
10. Middle East and Africa Immunohistochemistry Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Product (Antibodies, Equipment, Reagents, Kits)
10.2.2. By Application (Diagnostics, Drug Testing, Forensic applications)
10.2.3. By End User (Hospitals & Diagnostic Laboratories, Research Institutes, Others)
10.2.4. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa Immunohistochemistry Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Product
10.3.1.2.2. By Application
10.3.1.2.3. By End User
10.3.2. Saudi Arabia Immunohistochemistry Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Product
10.3.2.2.2. By Application
10.3.2.2.3. By End User
10.3.3. UAE Immunohistochemistry Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Product
10.3.3.2.2. By Application
10.3.3.2.3. By End User
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
12.1. Recent Development
12.2. Mergers & Acquisitions
12.3. Product Launches
13. Global Immunohistochemistry Market: SWOT Analysis
14. Porter’s Five Forces Analysis
14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products
15. Competitive Landscape
15.1. Business Overview
15.2. Product Offerings
15.3. Recent Developments
15.4. Financials (As Reported)
15.5. Key Personnel
15.6. SWOT Analysis
15.6.1 Thermo Fisher Scientific Inc.
15.6.2 F.Hoffmann-La Roche Ltd.
15.6.3 Merck KGaA.
15.6.4 Danaher Corporation.
15.6.5 Perkinelmer, Inc.
15.6.6 Bio-Rad Laboratories, Inc.
15.6.7 Cell Signaling Technology Inc.
15.6.8 Bio SB.
15.6.9 Agilent Technologies, Inc.
15.6.10 Abcam Plc.
16. Strategic Recommendations

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野(医療)の最新刊レポート

TechSci Research社の世界/地域別市場調査分野での最新刊レポート

本レポートと同じKEY WORD(industry)の最新刊レポート


よくあるご質問


TechSci Research社はどのような調査会社ですか?


テックサイリサーチ(TechSci Research)は、カナダ、英国、インドに拠点を持ち、化学、IT、環境、消費財と小売、自動車、エネルギーと発電の市場など、多様な産業や地域を対象とした調査・出版活... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/12/26 10:27

158.43 円

165.15 円

201.51 円

ページTOPに戻る